ImmuPharma PLC Cash Flow-to-Debt Ratio
ImmuPharma PLC cash flow-to-debt ratio. ImmuPharma PLC (IMM) has a Cash Flow-to-Debt Ratio of -0.81x as of June 2025, meaning its operating cash flow of GBX-1.00 Million could theoretically repay -1% of its total liabilities (GBX1.24 Million) in one year. Check how high is ImmuPharma PLC's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of ImmuPharma PLC (2004–2024)
Cash flow-to-debt ratio of ImmuPharma PLC from 2004 to 2024. Historical debt coverage capacity for ImmuPharma PLC across 21 annual periods. Check ImmuPharma PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
ImmuPharma PLC Cash Flow-to-Debt Ratio by Year (2004–2024)
ImmuPharma PLC cash flow-to-debt ratio by year from 2004 to 2024. Year-by-year debt coverage analysis for ImmuPharma PLC. For the full cash flow conversion analysis, see IMM cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.16x | GBX-1.77 Million | GBX1.52 Million | ▼ -42.1% |
| 2023 | -0.82x | GBX-1.36 Million | GBX1.67 Million | ▲ +49.3% |
| 2022 | -1.62x | GBX-2.35 Million | GBX1.45 Million | ▲ +47.0% |
| 2021 | -3.05x | GBX-4.83 Million | GBX1.58 Million | ▼ -15.5% |
| 2020 | -2.64x | GBX-3.33 Million | GBX1.26 Million | ▲ +66.7% |
| 2019 | -7.94x | GBX-4.22 Million | GBX531.87K | ▼ -74.0% |
| 2018 | -4.56x | GBX-4.72 Million | GBX1.03 Million | ▼ -48.9% |
| 2017 | -3.06x | GBX-4.42 Million | GBX1.44 Million | ▲ +45.0% |
| 2016 | -5.57x | GBX-6.49 Million | GBX1.16 Million | ▼ -104.6% |
| 2015 | -2.72x | GBX-4.15 Million | GBX1.52 Million | ▼ -49.5% |
| 2014 | -1.82x | GBX-2.49 Million | GBX1.37 Million | ▲ +16.1% |
| 2013 | -2.17x | GBX-3.91 Million | GBX1.80 Million | ▼ -39.5% |
| 2012 | -1.56x | GBX-3.26 Million | GBX2.09 Million | ▲ +18.0% |
| 2011 | -1.90x | GBX-3.37 Million | GBX1.77 Million | ▲ +56.1% |
| 2010 | -4.33x | GBX-6.84 Million | GBX1.58 Million | ▼ -337.2% |
| 2009 | 1.82x | GBX11.96 Million | GBX6.56 Million | ▲ +253.2% |
| 2008 | -1.19x | GBX-2.57 Million | GBX2.16 Million | ▲ +65.6% |
| 2007 | -3.46x | GBX-3.63 Million | GBX1.05 Million | ▼ -341.9% |
| 2006 | -0.78x | GBX-879.00K | GBX1.12 Million | ▼ -140.6% |
| 2005 | 1.93x | GBX27.00K | GBX14.00K | ▲ +285.7% |
| 2004 | 0.50x | GBX1.00K | GBX2.00K | — |